
Sun & UV
High UV in Miami in November: Why the Forecast Number Beats the Thermometer
Miami is reading a high UV index in early November. Here is what the EPA, WHO, CDC and FDA say to do about it, and how to build a simple layered routine.
6 min read
A new sunscreen active was added to the US monograph in June 2026. Here is what the order permits, what it excludes, and what to check on a label.
· 5 min read

In June 2026 the FDA added a new sunscreen active, bemotrizinol, to the over-the-counter sunscreen monograph. It was the first addition in more than two decades, and it raises an obvious shopper question: should you wait for it, switch to it, or ignore it? The short answer is that it changes what is possible on US shelves, but it will not change your sunscreen habits overnight. This guide covers what the order allows, what it does not, and how to read a label once products appear.
On June 10, 2026, the FDA issued Final Administrative Order OTC000039, adding bemotrizinol (often shortened to BEMT) to the sunscreen monograph known as M020. The request came from DSM Nutritional Products, and the proposed order had been issued on December 12, 2025. It is the first new sunscreen active added since 1999, and the first added through the streamlined order process created by the CARES Act. Before this action, 16 actives were permitted.
The order took effect on August 9, 2026, which is when DSM could begin lawfully marketing sunscreens containing the ingredient. That date also starts an 18-month exclusivity period for DSM, so broader availability from other manufacturers is expected in 2028 and beyond. In plain terms: a new filter is now legal, but it will not be on every shelf yet.
Bemotrizinol is an oil-soluble organic filter with a high molecular weight and low skin absorption. It provides broad-spectrum UVA and UVB coverage from a single ingredient. It differs from mineral filters such as zinc oxide and titanium dioxide, and it has been used in Europe and other markets for years. Dermatology Times describes it as photostable, meaning it keeps its effectiveness longer after sun exposure than some existing filters, though the article gives no quantitative data.
Two cautions apply to that last point. Photostability claims come from interviews and commentary in the sources above, not from a head-to-head trial, and no source compared it with specific existing products on a measured SPF basis. So treat 'more stable' as a reasonable expectation, not a measured result.
The order sets conditions that products must meet:
That last rule is easy to miss. Spray-on sunscreens in a pressurized can are not part of this order, because the FDA found the stability data submitted during the comment period insufficient, and the door is closed to aerosols and powders at this time. Pump sprays are fine.
The practical appeal is formulation. A single oil-soluble filter that covers UVA and UVB can make it easier to build lighter-feeling lotions, creams, and sticks, which matters because people use more of a sunscreen they like wearing. Dermatologists quoted by Dermatology Times point to its low absorption as a factor in the ruling, and note it is the first non-mineral filter added in decades to receive 'generally recognized as safe and effective' status.
It also matters for people who avoid mineral filters because of a white cast, or who dislike the filters currently available. A new option widens choice. It does not mean existing sunscreens stopped working.
Some shoppers hope a new filter will feel gentler. The sources here do not test that, and none reports irritation data, so no claim either way is supported yet. If your skin looks flushed or feels tight after sunscreens, the same approach applies as before: introduce one product at a time, use a small test area first, and keep the rest of your routine unchanged for a week.
Bemotrizinol is a meaningful regulatory change that gives US formulators a long-requested filter, and the order's conditions are clear: up to 6%, six months and older, no aerosols. For shoppers, the sensible move is to keep using a broad-spectrum sunscreen you will wear daily, apply it generously, and regard bemotrizinol products as an additional option when they reach shelves, judged by the same label checks as any other.
Rituelle reads your skin over time and adapts your routine to it.
Join the waitlist
Sun & UV
Miami is reading a high UV index in early November. Here is what the EPA, WHO, CDC and FDA say to do about it, and how to build a simple layered routine.
6 min read

Sun & UV
The two-hour rule is clear, but doing it over foundation is not. Here is what FDA, AAD and a dermatologist say about powders, sprays and the amount problem.
5 min read

Decoding Labels
Tone-up creams are still around, but a pink brightening base is not automatically sun protection. Three label checks, grounded in FDA guidance, separate real sunscreen from makeup.
5 min read